Rifabutin

Mycobutin

BrazilCancelledAuthorised 13 Jun 2011

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rifabutin

Mycobutin

BrazilCancelledAuthorised 13 Jun 2011

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ansatipin 150 MG Cápsulas DurasSpain · 150 mg · cápsula dura · Binesa 2002 S.L.

RifabutinUnited States · 150MG · capsule · I3 Pharms

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Rifabutin
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 13 Jun 2011
Registration: 102160223
Marketing authorisation holder: Laboratórios Pfizer Ltda
Procedure: Registered